Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Error in Results

The Original Investigation titled “Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer: A Randomized Clinical Trial,” published on June 1, 2026, was corrected to fix typographical errors in the text, including indicating that the trial was stopped for futility at 75% information, rather than 78%, and the number of participants lost to follow-up in the nivolumab group in…

We haven't written up this one. JAMA has the full story — the link below goes straight to it.

Read the original at jamanetwork.com →

More in Health & Medicine

More from Tuesday 13 October →